[go: up one dir, main page]

PT2598151T - Composições para o tratamento da infestação por vermes do coração - Google Patents

Composições para o tratamento da infestação por vermes do coração

Info

Publication number
PT2598151T
PT2598151T PT11743497T PT11743497T PT2598151T PT 2598151 T PT2598151 T PT 2598151T PT 11743497 T PT11743497 T PT 11743497T PT 11743497 T PT11743497 T PT 11743497T PT 2598151 T PT2598151 T PT 2598151T
Authority
PT
Portugal
Prior art keywords
infestation
heart
compositions
treatment
heart infestation
Prior art date
Application number
PT11743497T
Other languages
English (en)
Inventor
Forget Patrick
Kaltsatos Vassilios
Warin Stephan
Original Assignee
Ceva Sante Animale Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44534889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2598151(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale Sa filed Critical Ceva Sante Animale Sa
Publication of PT2598151T publication Critical patent/PT2598151T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT11743497T 2010-07-30 2011-07-29 Composições para o tratamento da infestação por vermes do coração PT2598151T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36947210P 2010-07-30 2010-07-30

Publications (1)

Publication Number Publication Date
PT2598151T true PT2598151T (pt) 2019-04-15

Family

ID=44534889

Family Applications (1)

Application Number Title Priority Date Filing Date
PT11743497T PT2598151T (pt) 2010-07-30 2011-07-29 Composições para o tratamento da infestação por vermes do coração

Country Status (14)

Country Link
US (2) US9351987B2 (pt)
EP (1) EP2598151B1 (pt)
JP (1) JP5981430B2 (pt)
KR (1) KR20140012013A (pt)
CN (1) CN103153313A (pt)
AU (1) AU2011284658B2 (pt)
BR (1) BR112013002175A2 (pt)
CA (1) CA2806153C (pt)
ES (1) ES2717621T3 (pt)
HR (1) HRP20190562T1 (pt)
HU (1) HUE043877T2 (pt)
MX (1) MX2013001040A (pt)
PT (1) PT2598151T (pt)
WO (1) WO2012013791A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130044330A (ko) 2010-07-30 2013-05-02 세바 상뜨 아니말르 사상충 체내 감염증을 조절하기 위한 조성물
EP3609470B1 (en) * 2017-04-13 2023-11-22 Ceva Santé Animale Implant for treating parasites infestations
US11235061B1 (en) * 2021-04-12 2022-02-01 Mountain Valley Md Inc. Topical solubilized ivermectin for inflammatory skin conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US473223A (en) * 1892-04-19 Tool for tightening wheel-tires
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device
AU660205B2 (en) * 1991-12-23 1995-06-15 Virbac, Inc Systemic control of parasites
US5439924A (en) 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
WO2001037811A1 (en) 1999-11-22 2001-05-31 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
AUPR602501A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
JP2005505280A (ja) * 2001-10-05 2005-02-24 ルビコン サイエンティフィック エルエルシー 有効成分を含む動物用飼料および該飼料を用いる方法
MX2011009678A (es) * 2009-03-17 2011-09-30 Intervet Int Bv Sistema de suministro de farmaco de lactona macrociclica.
KR20130044330A (ko) 2010-07-30 2013-05-02 세바 상뜨 아니말르 사상충 체내 감염증을 조절하기 위한 조성물

Also Published As

Publication number Publication date
EP2598151A1 (en) 2013-06-05
ES2717621T3 (es) 2019-06-24
CA2806153C (en) 2021-01-12
JP2013532706A (ja) 2013-08-19
HRP20190562T1 (hr) 2019-06-14
HUE043877T2 (hu) 2019-09-30
US9351987B2 (en) 2016-05-31
KR20140012013A (ko) 2014-01-29
US20160250244A1 (en) 2016-09-01
EP2598151B1 (en) 2018-12-26
MX2013001040A (es) 2013-05-28
WO2012013791A1 (en) 2012-02-02
AU2011284658A1 (en) 2013-02-28
CA2806153A1 (en) 2012-02-02
AU2011284658B2 (en) 2015-04-16
US20130172281A1 (en) 2013-07-04
BR112013002175A2 (pt) 2016-10-25
CN103153313A (zh) 2013-06-12
JP5981430B2 (ja) 2016-08-31

Similar Documents

Publication Publication Date Title
LT3222272T (lt) Farmacinė karbetocino kompozicija
SMT201600350B (it) Composizioni farmaceutiche
SMT201700050B (it) Composizioni anestetiche termogelificanti
DK2525798T3 (da) Anæstetisk formulering
CO6852076A2 (es) Composiciones farmacéuticas inhalables
HRP20150029T1 (xx) Farmaceutski pripravak za lijeäśenje metaboliäśkog sindroma
PL2593090T3 (pl) Kompozycje farmaceutyczne modulatora c-Met
DK3284467T3 (da) Nikotinholdige farmaceutiske sammensætninger
EP2760417A4 (en) Oral care compositions
BR112013015602A2 (pt) nova composição farmacèutica
PT2588067T (pt) Composto para saúde dentária
EE201300005A (et) Ravimkoostis
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
CO6801722A2 (es) Composiciones farmacéuticas
FR2958537B1 (fr) Composition dentaire
SMT201500005B (it) Composizione framaceutica inalabile
BR112013029637A2 (pt) composições para cuidados orais
EP2780051A4 (en) NEW IMPROVED FORMULATIONS FOR COATING MEDICAL DEVICES
HRP20160918T1 (hr) Postupak pripreme 6-klor-2,3,4,9-tetrahidro-1h-karbazol-1-karboksamida i njegovih prekursora
BR112013003275A2 (pt) composição de tratamento oral
EP2851085A4 (en) STERILIZED COMPOSITION
BR112013020339A2 (pt) composição de tratamento de sementes
IT1397838B1 (it) Composizione per la cura delle piante
EP2635307A4 (en) PHARMACEUTICAL COMPOSITIONS
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina